Home LiteratureArticle Details
PMID: 22860188 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

A simple method for quantifying functional selectivity and agonist bias.

ACS chemical neuroscience ·Vol. 3 ·No. 3 ·2012-03-21 ·Pages 193-203

Kenakin T, Watson C, Muniz-Medina V, Christopoulos A, Novick S

Abstract

Activation of seven-transmembrane (7TM) receptors by agonists does not always lead to uniform activation of all signaling pathways mediated by a given receptor. Relative to other ligands, many agonists are "biased" toward producing subsets of receptor behaviors. A hallmark of such "functional selectivity" is cell type dependence; this poses a particular problem for the profiling of agonists in whole cell test systems removed from the therapeutic one(s). Such response-specific cell-based variability makes it difficult to guide medicinal chemistry efforts aimed at identifying and optimizing therapeutically meaningful agonist bias. For this reason, we present a scale, based on the Black and Leff operational model, that contains the key elements required to describe 7TM agonism, namely, affinity (K(A) (-1)) for the receptor and efficacy (τ) in activating a particular signaling pathway. Utilizing a "transduction coefficient" term, log(τ/K(A)), this scale can statistically evaluate selective agonist effects in a manner that can theoretically inform structure-activity studies and/or drug candidate selection matrices. The bias of four chemokines for CCR5-mediated inositol phosphate production versus internalization is quantified to illustrate the practical application of this method. The independence of this method with respect to receptor density and the calculation of statistical estimates of confidence of differences are specifically discussed.

Keywords
Biased agonism drug discovery functional selectivity receptor methods receptor theory stimulus bias
MeSH Terms
Animals CHO Cells Carbachol/chemistry,pharmacology Cricetinae Cricetulus Guinea Pigs Ileum/drug effects,physiology Organ Culture Techniques Oxotremorine/chemistry,pharmacology Receptors, Cytoplasmic and Nuclear/agonists,physiology
Chemicals
Receptors, Cytoplasmic and Nuclear Oxotremorine Carbachol
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Kenakin Terry
Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599-7365, USA. Kenakin@email.unc.edu
Watson Christian
Muniz-Medina Vanessa
Christopoulos Arthur
Novick Steven
References (35)
35 references, click to expand
  1. Drug efficacy at G protein-coupled receptors.
    Annu Rev Pharmacol Toxicol. 2002;42:349-79 PMID: 11807176
  2. A modification of receptor theory.
    Br J Pharmacol Chemother. 1956 Dec;11(4):379-93 PMID: 13383117
  3. The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility.
    Science. 2005 Mar 4;307(5714):1434-40 PMID: 15637236
  4. Collateral efficacy in drug discovery: taking advantage of the good (allosteric) nature of 7TM receptors.
    Trends Pharmacol Sci. 2007 Aug;28(8):407-15 PMID: 17629960
  5. Cell surface expression of CCR5 and other host factors influence the inhibition of HIV-1 infection of human lymphocytes by CCR5 ligands.
    Virology. 2007 Aug 1;364(2):281-90 PMID: 17428518
  6. Distinct signaling profiles of beta1 and beta2 adrenergic receptor ligands toward adenylyl cyclase and mitogen-activated protein kinase reveals the pluridimensionality of efficacy.
    Mol Pharmacol. 2006 Nov;70(5):1575-84 PMID: 16901982
  7. Agonist-receptor efficacy. II. Agonist trafficking of receptor signals.
    Trends Pharmacol Sci. 1995 Jul;16(7):232-8 PMID: 7667897
  8. Activation of cannabinoid receptors in rat brain by WIN 55212-2 produces coupling to multiple G protein alpha-subunits with different potencies.
    Mol Pharmacol. 2000 May;57(5):1000-10 PMID: 10779385
  9. Pharmacological basis for functional selectivity of partial muscarinic receptor agonists.
    Eur J Pharmacol. 1996 Feb 22;297(3):283-91 PMID: 8666061
  10. Functionally selective M1 muscarinic agonists. 3. Side chains and azacycles contributing to functional muscarinic selectivity among pyrazinylazacycles.
    J Med Chem. 1995 Sep 1;38(18):3469-81 PMID: 7658434
  11. Interaction of delta-opioid receptors with multiple G proteins: a non-relationship between agonist potency to inhibit adenylyl cyclase and to activate G proteins.
    Mol Pharmacol. 1994 May;45(5):997-1003 PMID: 8190115
  12. Regulation of alpha2AR trafficking and signaling by interacting proteins.
    Biochem Pharmacol. 2007 Apr 15;73(8):1135-45 PMID: 17229402
  13. Deconvolution of complex G protein-coupled receptor signaling in live cells using dynamic mass redistribution measurements.
    Nat Biotechnol. 2010 Sep;28(9):943-9 PMID: 20711173
  14. Estimation of relative microscopic affinity constants of agonists for the active state of the receptor in functional studies on M2 and M3 muscarinic receptors.
    Mol Pharmacol. 2009 Feb;75(2):381-96 PMID: 18996972
  15. G protein-coupled receptor interacting proteins: emerging roles in localization and signal transduction.
    Cell Signal. 2002 Apr;14(4):297-309 PMID: 11858937
  16. Transduction of receptor signals by beta-arrestins.
    Science. 2005 Apr 22;308(5721):512-7 PMID: 15845844
  17. Beta-arrestin-biased ligands at seven-transmembrane receptors.
    Trends Pharmacol Sci. 2007 Aug;28(8):416-22 PMID: 17644195
  18. An operational model of pharmacological agonism: the effect of E/[A] curve shape on agonist dissociation constant estimation.
    Br J Pharmacol. 1985 Feb;84(2):561-71 PMID: 3978322
  19. Selectivity of agonists for the active state of M1 to M4 muscarinic receptor subtypes.
    J Pharmacol Exp Ther. 2009 Jan;328(1):331-42 PMID: 18824613
  20. Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes.
    Neuropsychopharmacology. 1999 Jun;20(6):612-27 PMID: 10327430
  21. Multiple signaling states of G-protein-coupled receptors.
    Pharmacol Rev. 2005 Jun;57(2):147-61 PMID: 15914464
  22. Implementation of BacMam virus gene delivery technology in a drug discovery setting.
    Drug Discov Today. 2007 May;12(9-10):396-403 PMID: 17467576
  23. Identification of orthosteric and allosteric site mutations in M2 muscarinic acetylcholine receptors that contribute to ligand-selective signaling bias.
    J Biol Chem. 2010 Mar 5;285(10):7459-74 PMID: 20051519
  24. G-Protein-coupled receptor-protein interactions: basis for new concepts on receptor structure and function.
    Clin Exp Pharmacol Physiol. 2005 Nov;32(11):979-87 PMID: 16405456
  25. Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery.
    Pharmacol Rev. 2010 Jun;62(2):265-304 PMID: 20392808
  26. Operational models of pharmacological agonism.
    Proc R Soc Lond B Biol Sci. 1983 Dec 22;220(1219):141-62 PMID: 6141562
  27. Independent beta-arrestin2 and Gq/protein kinase Czeta pathways for ERK stimulated by angiotensin type 1A receptors in vascular smooth muscle cells converge on transactivation of the epidermal growth factor receptor.
    J Biol Chem. 2009 May 1;284(18):11953-62 PMID: 19254952
  28. STIMULANT ACTIONS OF VOLATILE ANAESTHETICS ON SMOOTH MUSCLE.
    Br J Pharmacol Chemother. 1964 Apr;22:356-65 PMID: 14190470
  29. GPCR functional selectivity has therapeutic impact.
    Trends Pharmacol Sci. 2007 Aug;28(8):390-6 PMID: 17629962
  30. Composition and function of g protein-coupled receptor signalsomes controlling mitogen-activated protein kinase activity.
    J Mol Neurosci. 2005;26(2-3):253-64 PMID: 16012199
  31. Multiple mechanisms of serotonergic signal transduction.
    Life Sci. 1987 Aug 31;41(9):1051-64 PMID: 2441225
  32. Evaluating cellular impedance assays for detection of GPCR pleiotropic signaling and functional selectivity.
    J Biomol Screen. 2009 Mar;14(3):246-55 PMID: 19211780
  33. The ethyleneiminium ion as the active species in 2-haloalkylamine compounds.
    Br J Pharmacol Chemother. 1957 Dec;12(4):489-97 PMID: 13489180
  34. '7TM receptor allostery: putting numbers to shapeshifting proteins.
    Trends Pharmacol Sci. 2009 Sep;30(9):460-9 PMID: 19729207
  35. Analysis of allosterism in functional assays.
    J Pharmacol Exp Ther. 2005 Nov;315(2):740-54 PMID: 16046613
Article Info
Journal
ACS chemical neuroscience
Abbr.
ACS Chem Neurosci
ISSN
1948-7193
Published
2012-03-21
Epub
2011-00-20
Pages
193-203
Language
English
Region
United States
NLM ID
101525337
PMCID
PMC3369801
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com